BMS-605541 is an Orally Active VEGFR-2 Kinase Inhibitor for Cancer Research
Tumor-induced angiogenesis, or the formation of new capillary networks between neoplastic cells and endothelial cells of the host, is required for solid tumor growth and metastases. In addition, the Vascular…